The effects of combined antifolates on inhibition of growth of murine leukemia cells cultured in vitro

• Autorzy: Balinska M. , Szablewska I. , Janiszewska D. , Bartuzi K. , Pawelczak K.
• Języki publikacji: EN

Abstrakty

EN

The synergistic effect of trimetrexate (TMTX) and sulphonamide derivatives of quinazoline on the cultured 5178Y murine leukemia cells was examined. On exposure to the slightly inhibitory concentrations of TMTX (0.1 nM) in combination with 2-desamino-2-methyl-10-propargyl-5,8-dideaza-pteroyl-sulphoglyc ine (DMPDDSF) (0.02 microM) a synergistic inhibitory effect of the antifolates on cell growth was observed. These two drugs in the same combination caused also synergistic inhibition of de novo synthesis of thymidylate in intact cells as measured by tritium release from [5-(3)H]deoxyuridylate. This was accompanied by a marked reduction in intracellular concentration of 5,10-methylenetetrahydro-pteroyl-polyglutamate (5,10CH2H4PteGlu(n)) (0.2 microM) and dihydropteroyl-polyglutamate (0.12 microM). In these conditions de novo biosynthesis of purine was decreased by 50%. These observations show that growth inhibition by combined antifolates is mediated by intracellular depletion of the substrate of thymidylate synthase -- 5,10CH2H4PteGlu(n). The results obtained strongly suggest that under certain conditions inhibition of thymidylate synthesis by DMPDDSF is intensified by prior application of TMTX -- an inhibitor of dihydrofolate reductase.

Słowa kluczowe

EN

folate; leukemia; thymidylate synthase; growth inhibition; trimetrexate; antifolate

• Wydawca: -
• Czasopismo: Acta Biochimica Polonica
• Rocznik: 1997
• Tom: 44
• Numer: 4
• Opis fizyczny: p.743-750,fig.

Twórcy

autor

Balinska M.

• Polish Academy of Sciences, L.Pasteura 3, 02-093 Warsaw, Poland

autor

Szablewska I.

autor

Janiszewska D.

autor

Bartuzi K.

autor

Pawelczak K.

Bibliografia

• 1. Bertino, J.R. (1979) Toward improved selec­tivity in cancer chemotherapy. Cancer Res. 39, 293-304.
• 2. Ensminger. W.D. (1984) Clinical pharmacol­ogy of folate analogs; in Folate Antagonists as Therapeutic Agents (Sirotniak, F.M., Bur- chall, J.J. & Ensminger, W.D., eds.) vol. 2, pp. 133-165, Academic Press, Orlando, Fl.
• 3. Tattersall, M.H.N. (1984) Clinical utility of methotrexate in neoplastic disease; in Folate Antagonists as Therapeutic Agents (Sirot­niak, F.M., Burchall, J.J. & Ensminger, W.D., eds.) vol. 2, pp. 165-189, Academic Press, Orlando, Fl.
• 4. Weinblatt, M.E., Coblyn, J.S., Fox, D.A. & Praser, P.A. (1985) Efficacy of low methotr­exate in rheumatoid arthritis. N. Engl. J. Med. 312, 818-822.
• 5. Jolivet, J., Cowan, K.H., Curt, G.A., Clende- man, N.J. & Chabner, B.A. (1983) The phar­macology and clinical use of methotrexate. N. Engl. J. Med. 309, 1094-1164.
• 6. Ress, R.B., Bennt, J.R., Maibach, H.J. & Arhold, H.L. (1967) Methotrexate for psoria­sis. Arch. Dermatol. 95, 2-10.
• 7. Jackson, R.C. & Grindey, G B. (1984) The biochemical basis for methotrexate cytotoxic­ity; in Folate Antagonists as Therapeutic Agents (Sirotniak, F.M., Burchall, J.J. & Ensminger, W.D., eds.) vol. 1, pp. 290-316, Academic Press, Orlando, Fl.
• 8. Huennekens, F.M., Vitols, K.S., Whiteley, J.M. & Nett, U.G. (1976) Dihydrofolate reduc­tase. Methods Cancer Res. 13, 199-225.
• 9. Allcgra, C.J., Chabner, B.A., Drake, J.C., Lutz, R., Rodbard, D. & Jolivet, J. (1985) Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates. J. Biol. Chem. 260, 9720-9726.
• 10. Allegra, C.J., Huang, K., Yeh. G.C., Drake, J.C. & Baram, J. (1987) Evidence for direct inhibition of de novo purine synthesis in hu­man MCF-7 breast cells as a principal mode of metabolic inhibition by methotrexate. J. Biol. Chem. 262, 13520-13526.
• 11. Allcgra, C.J., Drake, J.C., Jolivet, J. & Chab­ner, B.A. (1985) Inhibition of phosphoribosy- laminoimidazolecarboxyamide transformy- lase by methotrexate polygl utamate. Proc. Natl. Acad. Sci. U.S.A. 82, 4881-4885.
• 12. Jones, T.R., Calvert, A.H., Jackman, A.L., Brown, S.J. & Harrap, K.R. (1981) A potent antitumor quina2oline inhibitor of thymidy­late synthase: Synthesis, biological properties and therapeutic results in mice. Eur. J. Can­cer 17, 11-32.
• 13. Jackson, R.D., Fry, D.W., Boritzki, T.J., Bressler, J.A., Leopld, W.R., Sloan, S.J. & Elslager, E I. (1984) Biochemical pharmacol­ogy of liophilic antifolate trimetrexate; in Ad- vances in Enzyme Regulation ( Weber, G., ed.) vol. 22, pp. 187-206, Pergamon Press, Oxford, England.
• 14. Jackson, R.C., Jackman, A.L. & Calvert, A.H. (1983) Biochemical effects of quinazoline in­hibitor of thymidylate synthase, M4(iV-<(2- amino-4-hydroxy-6-quinazolinyl)methyl)pro-p -2-ynylamino)benzoyl)-L-glutamic acid (CB 3717) on human lymphoblastoid cells. Bio- chem. Pharmacol. 24, 3783-3790.
• 15. Galivan, J., Nimec, Z. & Rhee, M. (1987) Synergistic growth inhibition of rat hepatoma cells exposed in vitro to N10-propargyl-5,8- dideazafolate with methotrexate or the lipo­philic antifolate trimetrexate in vitro. Cancer Res. 47, 5256-5260.
• 16. Diddens, H., Nilthammer, D. & Jackson, R.C. (1983) Patterns of cross-resistance to antifo­late drugs trimetrexate, metoprim, homofo-late and CB 3717 in human lymphoma and osteosarcoma cells resistant to methotrexate. Cancer Res. 43, 5286-5292.
• 17. Galivan, J., Rhee, M.S., Johnson, T.B., Dil- with, R., Nair, M.G., Bunni, M. & Priest, D.G. (1989) The role of cellular folates in the en­hancement of activity of thymidylate syn­thase inhibitor, 10-propargyl-5,8-dideazafo- late against hepatoma cells in vitro by inhibi­tors of dihydrofolate reductase. J. Biol. Chem. 264, 10685-10692.
• 18. Jacewicz, D., Kaczorowska, K., Szablewska, T. & Balińska, M. (1995) Effect of antifolates on intracellular level of folates and folate en­zymes in 5178Y murine leukemia cells. J. Exp. Clin. Cancer Res. 14, 24-26.
• 19. Pawełczak. K., Makowski, M., Kempny, M., Dzik, J.M., Balińska, M. & Rode, W. (1993) Sulphonamide antifolates inhibiting thymi­dylate synthesis, enzyme inhibition and cyto­toxicity. Adv. Exp. Med. Biol. 338, 625-627.
• 20. Blakley, R.L. (1960) Crystalline dihydrop- terylglutamic acid. Nature 188, 231-232.
• 21. Bretner, M., Kulikowski, T., Dzik, J.M., Balińska, M., Rode, W. & Shugar, D. (1993) 2-Thioderivatives of dUrd and 5-fluoro dUrd and their 5'-monophosphates, synthesis, in­teraction with tumour thymidylate synthase and in vitro antitumour activity. J. Med. Chem. 36, 3613-3617.
• 22. McGuire, J.J., Hsieh, P., Coward, J.K. & Bertino, J.R. (1980) Enzymatic synthesis of folylpolyglutamates. Characterization of the reaction and its products. J. Biol. Chem. 255, 5776-5788.
• 23. Sikora, E., Krzyżanowski, L. & Rzeszotarska, B. (1989) A rapid, sensitive, nonradioactive assay for scrum y-glutamyl hydrolase using synthetic ;V(4-aminohenzoyl)-y-oligo(L-gluta- mic acids) as substrates. Pteridines 1, 175-178.
• 24. Bradford, M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248 254.
• 25. Bunni, M.. Doig, M.T., Donato, H., Kesaran, V. & Priest, D.G. (1988) Role of methyle- netetrahydrofolate depletion in methotr- exate-mediated intracellular thymidylate synthesis inhibition in cultured L1210. Can­cer Res. 48, 3398-3404.
• 26. Rhee, M.S., Baliriska, M., Bunni, M., Priest, D.G., Maley, G.F., Maley, F. & Galivan, J. (1990) The role of substrate depletion in inhi­bition of thymidylate biosynthesis by dihydro­folate reductase inhibitor trimetrexate in cul­tured hepatoma cells. Cancer Res. 50, 3979- 3984.
• 27. Chou, T.C. & Talalay, P. (1984) Quantitative analysis of dose-effect relationship: The com­bined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22, 27-55.
• 28. Matherly, L.H., Barlowc, C.K., Philips, V.M. & Goldman, I.D. (1987) The effects of 4- aminofolates on 5-formyltetrahydrofolate me­tabolism in L1210 cells. J. Biol. Chem. 262, 710-717.
• 29. Seither, R.L., Trent, D.T., Mikalecky, D.C., Rape, T.J. & Goldman, I.D. (1989) Folate pool interconversion and inhibition of biosynthetic processes after exposure of L1210 leukemia cells to antifolates. J. Biol. Chem. 264,17016- 17023.